Supreme Court hears mifepristone arguments as protests gather outside: Highlights

"Abortion providers responded to today's oral arguments by emphasizing the safety and effectiveness of mifepristone, stressing that reduced access to the drug could threaten public health. “The very existence of this case puts every other FDA-approved medication at risk of being taken off the market or restricted for political reasons,” Alexis McGill Johnson, CEO of Planned Parenthood Federation of America, said in a statement...."
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.